Delivery Order SPE2DB22D2006-SPE2DB24FW3MD

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,747.52 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565760585 - Mupirocin 2% Ointment 22GM. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $10,257.69, is for the provision of 4,557,475,382 units of 2% Mupirocin Cream in 15 gram tubes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,256.71 contract is for the supply of Mupirocin 2% cream. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company, to provide Mupirocin 2% Ointment 22g. The delivery order has a ceiling value of $1,003.68 and a period of performance through March 22, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with a...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,463.24 contract is for the supply of Mupirocin 2% Ointment, a topical antibiotic medication used to treat bacterial skin infections. The order was placed under a DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999, which serves as a primary vehicle for providing pharmaceutical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,788.68 firm-fixed-price contract is for the supply of 4,565,426,384 units of Mupirocin 2% cream, a topical antibiotic ointment, with a period of performance through August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under an existing Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mupirocin 2% Ointment, 22 grams. The contract, valued at $7,220.63, was awarded on August 24, 2022, with an ultimate completion date of August 25, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,250.04, is a delivery order for the supply of Mupirocin 2% Ointment. It is a firm fixed-price contract with a performance period ending on May 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mupirocin 2% Ointment, a prescription topical antibiotic. The contract has a ceiling value of $1,030.32 and a completion date of August 30, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,817.49 award is for the supply of Mupirocin 2% Ointment 22GM, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3MD
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,085.74 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,800,626 units of Mupirocin 2% Ointment (22 g). This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is intended to be completed by September 16, 2024.

Generated 12/13/24, 9:28 AM